Código QR

Immunotherapeutic treatment of inflammation in mice exposed to methamphetamine

IntroductionCurrently, there are no FDA-approved medications to treat methamphetamine addiction, including the inflammatory, neurotoxic, and adverse neuropsychiatric effects. We have shown that partial (p)MHC class II constructs (i.e., Recombinant T-cell receptor Ligand – RTL1000), comprised of the...

Descrición completa

Gardado en:
Principais autores: Jennifer M. Loftis, Sankrith Ramani, Evan J. Firsick, Rebekah Hudson, Anh Le-Cook, Kevin S. Murnane, Arthur Vandenbark, Renee L. Shirley
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Psychiatry
Assuntos:
addiction
chemokine
drug discovery
frontal cortex
inflammation
methamphetamine
Acceso en liña:https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1259041/full
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares